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deionized water and eluted into a collector of 0.35 mm i.d. 
PTFE tubing. 75 gl of the collected eluate was then pumped 
into the graphite tube. The reproducibility of FI  peak gradients 
was exploited through precise timing of the collection and dis- 
pensing of the eluate fraction so that the end sections of the 
eluate bolus, which contained only low analyte lement concen- 
trations were discarded. The complete cycle of operation took 
150 s which conveniently fitted into the time interval between 
successive graphite furnace firings. 
Results 
A 26-fold enhancement in the peak area compared to the direct 
introduction of 50 gl was obtained with 60 s preconcentration. 
The precision for 0.1 gg/1 Pb (n = l l )  was 1.9% r.s.d., and a 
detection limit of 0.003 ~tg/1 (3 a) was achieved. Determination 
of Pb in sea water samples howed that the interfering matrix 
was almost completely removed uring preconcentration, and 
determinations were made without using chemical modifiers. 
Results obtained for sea water standard reference materials 
using matrix-matched standards, and for river water using 
simple aqueous standards agree well with certified values 
(Table 1). 
Conclusion 
The results how that the principles and techniques of FI could 
be exploited to improve the performance and extend the capa- 
bilities of GF-AAS. It is quite exciting to anticipate the vast 
number of possibilities for further improvement of the GF- 
AAS technique when the wealth of chemical literature on ion- 
exchange, chelate formation, and solvent extraction is re- 
explored in the context of a new solution handling concept. The 
Table 1. Determination of lead in standard reference materials 
for sea and river water using FI on-line sorbent extraction 
preconcentration GF-AAS 




Concentration ( g/1 Pb) 
certified found a 
NASS-2 sea water 2 39 ± 6 37 ± 2 
CASS-1 sea water 1 251 ± 27 267 ± 6 
CASS-2 sea water 2 19 ± 6 22 ± 1 
SLRS-1 river water 1 106 ± 11 117 ± 2 
a Average and standard deviation of 6 preconcentrations/ 
determinations 
combination of GF-AAS with FI automated on-line sample 
manipulation and with the appropriate chemistry could create 
new analytical systems with unrivaled sensitivity and selectivity. 
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Human pancreatic secretory trypsin inhibitor (PSTI), a Kazal- 
type serine protease inhibitor, was isolated and extensively 
characterized byBartelt et al. [1]. PSTI has been thought o exist 
only in the pancreas having the function to prevent autoactiva- 
tion of trypsinogen in the pancreas and the pancreatic juice. 
Ogawa and coworkers ([4], review), however, found that im- 
munoreactive PSTI is present also in other tissues and reported 
that raised serum levels of PSTI occur in various malignant 
diseases and after severe injuries. 
Only very recently the elucidation of the amino acid sequence 
(manuscript in preparation) of HUSI-II, the acrosin-trypsin 
inhibitor of human semen [2], demonstrated unequivocally that 
this inhibitor also belongs to the Kazal family. The findings of 
Ogawa and coworkers [4] prompted us to investigate whether 
the plasma concentration of HUSI-II shows a similar response 
as that of PSTI in patients with polytrauma. 
Methods 
The clinical significance and pathophysiological re evance of 
a series of biochemical parameters was investigated in a 
comprehensive study including 69 patients with polytrauma. 
The average Injury Severity Score (ISS) was 36. The patients 
were subdivided in three groups: 11 patients died due to 
multiorgan failure, 29 patients overcame multiorgan failure and 
29 survived without manifestation of organ dysfunction. 
Radioimmunoassays for human PSTI and HUSI-II have 
been developed in our institute. They allow the determination 
of these two polypeptides in plasma in concentrations a low as 
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Fig. l. Time course of C-reactive protein (CRP), pancreatic 
secretory trypsin inhibitor (PSTI), and neopterin (mean _-t- SEM) 
in polytraumatized patients. The patients were subdivided in 
three groups: letal multiorgan failure (n = 11) x . . . .  x ;  
reversible multiorgan failure (n = 29) © . . . .  ©; no organ 
failure (n = 29), + . . . .  + 
available (Henning, Berlin). C-Reactive protein (CRP) was 
determined by an immunodiffusion assay (Behring-Werke AG, 
Marburg). 
Results and discussion 
Several of the specific and unspecific inflammation parameters 
of humoral and cellular systems investigated in this study 
allowed a discrimination of patients with lethal outcome and 
those who survived with and without multiorgan failure, respec- 
tively. The plasma concentrations of neopterin (endproduct of 
the macrophage GTP metabolism [3], CRP and PSTI permitted 
already on the third posttraumatic day a discrimination of 
surviving and not surviving patients (mean survival time: 16 d, 
range: 6 -  28 d). 
The plasma concentration of PSTI in healthy persons is 
about 6 lxg/1 and that of HUSI-I I  about 0.3 Ixg/1 which is close 
to the lower limit of detection i  the routine radioimmunoassay. 
In plasma ofpolytrauma patients PSTI levels rise almost steadily 
from day 2 to day 12 post trauma. This delayed increase is 
similar to that of neopterin and somewhat different from the 
steeper increase of the acute phase reactant CRP (Fig. 1). 
The highest PSTI concentration observed in our study was 
1.5 mg/1. 
In contrast to PSTI no change in the concentration f HUSI- 
II in the plasma of patients with polytrauma could be detected. 
Concluding from its comparatively high plasma concentra- 
tion and the significant increase after severe injury, PSTI seems 
to have other, not yet understood functions in addition to its 
role to prevent autoactivation of trypsinogen. In contrast, the 
low plasma concentration of HUSI-I I  and the fact that no 
concentration i crease is observed in polytrauma patients indi- 
cate that HUSI-I I  has not specific function under acute phase 
conditions. It may be deduced further that the physiological 
role of HUSI-I I  is restricted to the reproductive system where 
it has to prevent deleterious proteolysis by acrosin. 
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